Acg Wealth Abb Vie Inc. Transaction History

Acg Wealth

$437 Million
Q3 2022

A detailed history of Acg Wealth transactions in Abb Vie Inc. stock. As of the latest transaction made, Acg Wealth holds 8,284 shares of ABBV stock, worth $1.52 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

8,284

Previous 7,906 4.78%

Holding current value

$1.52 Million

Previous $1.21 Million 8.18%

% of portfolio

0.25%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $50,731 - $58,185	378 Added 4.78%	8,284 $1.11 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $97,985 - $124,571	712 Added 9.9%	7,906 $1.21 Million
Q1 2022 Apr 07, 2022	SELL	$131.98 - $163.75 $778,813 - $966,288	-5,901 Reduced 45.06%	7,194 $1.17 Million
Q4 2021 Jan 18, 2022	SELL	$107.43 - $135.93 $210,885 - $266,830	-1,963 Reduced 13.04%	13,095 $1.77 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $47,560 - $53,988	-447 Reduced 2.88%	15,058 $1.62 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $90,059 - $100,331	-856 Reduced 5.23%	15,505 $1.75 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $19,539 - $21,510	191 Added 1.18%	16,361 $1.77 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $26,320 - $35,535	-327 Reduced 1.98%	16,170 $1.73 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $53,092 - $62,312	618 Added 3.89%	16,497 $1.45 Million
Q2 2020 Oct 07, 2020	SELL	$73.37 - $98.18 $513,736 - $687,456	-7,002 Reduced 30.6%	15,879 $1.56 Million
Q1 2020 Oct 07, 2020	SELL	$64.5 - $97.79 $156,090 - $236,651	-2,420 Reduced 9.56%	22,881 $1.74 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $20,412 - $25,540	-283 Reduced 1.11%	25,301 $2.24 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $2,078 - $2,498	33 Added 0.13%	25,584 $1.94 Million
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $307,738 - $393,362	-4,684 Reduced 15.49%	25,551 $1.86 Million
Q1 2019 Apr 25, 2019	SELL	$77.14 - $90.79 $512,903 - $603,662	-6,649 Reduced 18.03%	30,235 $2.44 Million
Q4 2018 Jan 14, 2019	BUY	$77.85 - $96.01 $50,057 - $61,734	643 Added 1.77%	36,884 $3.4 Million
Q3 2018 Oct 09, 2018	SELL	$88.91 - $98.84 $138,966 - $154,486	-1,563 Reduced 4.13%	36,241 $3.43 Million
Q2 2018 Jul 26, 2018	BUY	$89.78 - $106.23 $165,374 - $195,675	1,842 Added 5.12%	37,804 $3.5 Million
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $214,659 - $287,448	2,333 Added 6.94%	35,962 $3.4 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $472,160 - $517,763	5,272 Added 18.59%	33,629 $3.25 Million
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $479,799 - $612,852	-6,869 Reduced 19.5%	28,357 $2.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	35,226	35,226 $2.55 Million

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.

Account